256 related articles for article (PubMed ID: 11832713)
1. Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection.
Neves M; Ciofu C; Larousserie F; Fleury J; Sibony M; Flahault A; Soubrier F; Gattegno B
J Urol; 2002 Mar; 167(3):1276-81. PubMed ID: 11832713
[TBL] [Abstract][Full Text] [Related]
2. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
3. [Application of microsatellite alteration of urine sediment in the early diagnosis of bladder cancer].
Qiu L; Cong X; Tan Y
Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):483-6. PubMed ID: 11235570
[TBL] [Abstract][Full Text] [Related]
4. Comparison of screening methods in the detection of bladder cancer.
Ramakumar S; Bhuiyan J; Besse JA; Roberts SG; Wollan PC; Blute ML; O'Kane DJ
J Urol; 1999 Feb; 161(2):388-94. PubMed ID: 9915409
[TBL] [Abstract][Full Text] [Related]
5. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
[TBL] [Abstract][Full Text] [Related]
6. [The diagnostic value of microsatellite LOH analysis and the prognostic relevance of angiogenic gene expression in urinary bladder cancer].
Szarvas T
Magy Onkol; 2009 Dec; 53(4):385-9. PubMed ID: 20071311
[TBL] [Abstract][Full Text] [Related]
7. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas].
Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058
[TBL] [Abstract][Full Text] [Related]
8. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.
Ito H; Kyo S; Kanaya T; Takakura M; Koshida K; Namiki M; Inoue M
Clin Cancer Res; 1998 Nov; 4(11):2807-10. PubMed ID: 9829746
[TBL] [Abstract][Full Text] [Related]
9. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
[TBL] [Abstract][Full Text] [Related]
10. Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer.
Eissa S; Swellam M; Ali-Labib R; Mansour A; El-Malt O; Tash FM
J Urol; 2007 Sep; 178(3 Pt 1):1068-72. PubMed ID: 17644139
[TBL] [Abstract][Full Text] [Related]
11. Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment.
Szarvas T; Kovalszky I; Bedi K; Szendroi A; Majoros A; Riesz P; Füle T; László V; Kiss A; Romics I
Oncol Rep; 2007 Aug; 18(2):405-9. PubMed ID: 17611663
[TBL] [Abstract][Full Text] [Related]
12. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.
Siracusano S; Niccolini B; Knez R; Tiberio A; Benedetti E; Bonin S; Ciciliato S; Pappagallo GL; Belgrano E; Stanta G
Eur Urol; 2005 Mar; 47(3):327-33. PubMed ID: 15716196
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
[TBL] [Abstract][Full Text] [Related]
14. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
Friedrich MG; Erbersdobler A; Schwaibold H; Conrad S; Huland E; Huland H
J Urol; 2000 Mar; 163(3):1039-42. PubMed ID: 10688045
[TBL] [Abstract][Full Text] [Related]
15. Multiplex polymerase chain reaction for microsatellite analysis of urine sediment cells: a rapid and inexpensive method for diagnosing and monitoring superficial transitional bladder cell carcinoma.
Bartoletti R; Cai T; Dal Canto M; Boddi V; Nesi G; Piazzini M
J Urol; 2006 Jun; 175(6):2032-7; discussion 2037. PubMed ID: 16697794
[TBL] [Abstract][Full Text] [Related]
16. Genetic detection of bladder cancer by microsatellite analysis of p16, RB1 and p53 tumor suppressor genes.
Sourvinos G; Kazanis I; Delakas D; Cranidis A; Spandidos DA
J Urol; 2001 Jan; 165(1):249-52. PubMed ID: 11125419
[TBL] [Abstract][Full Text] [Related]
17. [Microsatellite instability in urine sediments from patients with transitional cell carcinoma of bladder and its clinical value].
Lü Y; Tang D; Yu L; Ding Y; Liu L; Guo Y
Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):294-6. PubMed ID: 12828175
[TBL] [Abstract][Full Text] [Related]
18. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
Bialkowska-Hobrzanska H; Bowles L; Bukala B; Joseph MG; Fletcher R; Razvi H
Mol Diagn; 2000 Dec; 5(4):267-77. PubMed ID: 11172490
[TBL] [Abstract][Full Text] [Related]
19. [Microsatellite analysis in exfoliated cells from urinary sediment. Its utility for the detection of bladder cancer. Comparison with urinary cytology].
Molina Burgos R; Millán Salvador JM; Oltra Soler JS; Jiménez Cruz JF
Actas Urol Esp; 2003 Sep; 27(8):618-28. PubMed ID: 14587237
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer.
Schneider A; Borgnat S; Lang H; Régine O; Lindner V; Kassem M; Saussine C; Oudet P; Jacqmin D; Gaub MP
Cancer Res; 2000 Aug; 60(16):4617-22. PubMed ID: 10969815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]